Professor Mark Lawler
Board member
Prof Mark Lawler is an internationally renowned scientist with over 200 papers including key publications in the highest impact journals. His work has been recognised by numerous national and international awards.
He is Associate Director of Health Data Research Wales-Northern Ireland and is Scientific Director of DATA-CAN, the UK’s National Health Data Research Hub for Cancer.
Mark has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was architect of the European Cancer Patient's Bill of Rights, which he launched in the European Parliament with colleagues on World Cancer Day 2014. The European Cancer Organisation has won the prestigious 2018 European Health Award.
Mark’s work on addressing inequalities and access issues in relation to cancer care formed the centrepiece in the development by the European Cancer Organisation of the European Code of Cancer Practice, which Mark launched (virtually) with EU Health and Food Safety Commissioner Stella Kyriakides in Brussels in September 2020.
Mark’s work on Covid-19 and its impact on cancer services and cancer patients has received international attention and he co-chairs the European Cancer Organisation’s Special Focused Network on Covid-19 and cancer, which launched its Seven-Point plan to Build Back Better (and smarter) from Covid. He presented recent data on Covid’s impact on cancer in Europe to the Europe Beating Cancer Committee in the European Parliament and launched the European Cancer Organisation’s pan-European 'Time To Act' campaign to ensure that Covid-19 does not stop us from tackling cancer. This work recently received the prestigious Royal College of Physicians Excellence in Patient Care Award.
Mark recently received the Irish Association for Cancer Research’s Outstanding Contribution to cancer research award, for his pioneering work on cancer research and cancer care on the island of Ireland. Mark is Chair of the International Cancer Benchmarking Partnership, an international collaborative that employs a data- driven approach to improve outcomes for cancer patients.